QUESTLAB — Quest Laboratories Income Statement
0.000.00%
- IN₹1.79bn
- IN₹1.89bn
- IN₹825.63m
- 51
- 62
- 69
- 68
Annual income statement for Quest Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 304 | 595 | 616 | 826 |
Cost of Revenue | ||||
Gross Profit | 58.8 | 150 | 198 | 303 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 293 | 535 | 544 | 676 |
Operating Profit | 10.2 | 60.3 | 72.7 | 150 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 7.89 | 57.7 | 69.6 | 144 |
Provision for Income Taxes | ||||
Net Income After Taxes | 6.55 | 41 | 50.3 | 101 |
Net Income Before Extraordinary Items | ||||
Net Income | 6.55 | 41 | 50.3 | 101 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 6.55 | 41 | 50.3 | 101 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.399 | 2.52 | 3.07 | 8.46 |
Dividends per Share |